Objectives: 1. Describe the treatment for the 5 tick-borne illnesses discussed 2. Recall the 3 stages of Lyme disease

Objectives: 1. Describe the use of methadone to treat acute opioid withdrawal 2. Recall the non-opioid agents that may be used to treat opioid withdrawal in the ED setting

Objectives: 1. Describe the different indications for ketamine 2. Recall the evidence level of the PADIS guidelines for ketamine as an analgesic i ICU postsurgical patients

Objectives: 1. Describe the suggested steps in the MUE process 2. Recall the pitfalls to avoid when doing an MUE

Objectives: 1. Describe the different populations that might benefit from TDM of beta-lactams 2. Recall the barriers to implementing TDM in practice

Objectives: 1. Describe the different types of digoxin toxicity 2. Recall the dose of digoxin fab fragments for treatment of toxicity

Objectives: 1. Describe the role of IV digoxin for rate control in the ICU 2. Recall the time to onset of effect for digoxin

Objectives: 1. Describe the risk factors for intubation related cardiac arrest 2. Recall the clinical significance of hematochezia

Objectives: 1. Describe the role of MRSA screening for CAP 2. Recall the two reasons where a negative MRSA screen may be disregarded

Objectives: 1. Describe the role of anti-Xa levels in evaluating the anticoagulant activity of apixaban and rivaroxaban 2. Recall the therapeutic range of anti-Xa levels for enoxaparin

Objectives: 1. Describe 5 steps a pharmacist can take to prevent awareness with paralysis 2. Recall the prevalence of awareness with paralysis in the ED compared to the OR

Objectives: 1. Describe the decision process for choosing warm vs cold compresses in extravasation treatment 2. Recall alternatives to phentolamine in the setting of shortage